Table 2.
Key recommendations for supportive treatment and survivorship care for SCCHN
Pre-treatment evaluation | ||
Multidisciplinary approach | Assessment and evaluation by multiple subspecialties of oncology | |
Possible treatment de-intensification or organ preservation for HPV-positive or locoregional disease | ||
Consider reconstruction if extensive surgical resection is required | ||
Speech/language therapy | Voice therapy (use electrolarynx if necessary) | |
Swallow exercise | ||
Close follow-up and objective assessment of speech and swallowing function (patient-reported symptoms do not accurately reflect the level of morbidity) | ||
Nutrition | Prophylactic or elective G tube feeding | |
Dental and oral care | ||
Survivorship care | ||
Cancer surveillance | Cancer-specific history and physical exam every 1 to 3 months for the first year after the primary treatment, every 2 to 6 months in the second year, every 4 to 8 months in the 3rd to 5th years, and annually after the 5th year | |
Patient education about the signs of early recurrence | ||
Adequate and timely referral to oncologist or ENT specialist if detailed exam is needed | ||
Adhere to national guidelines for second primary cancer prevention | ||
Substance abuse | Proper counseling on smoking cessation and alcohol abstinence | |
Screen for underlying mood disorder | ||
Referral to cessation resources or psychiatrist if needed | ||
Body and self-image | Assessment of body and self-image concerns | |
Referral to psychiatrist if needed | ||
Mood disorder | Evaluate survivors for depression, anxiety and screen for relevant social/financial/emotional distresses | |
Social care for financial or employment challenges | ||
Addiction recovery assistance for substance abuse | ||
Pharmacologic treatment as indicated | ||
Timely referral to psychiatrist |
SCCHN, squamous cell carcinoma of head and neck; HPV, human papilloma virus; ENT, ear nose throat.